A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Condition(s):Multiple SclerosisLast Updated:May 19, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Multiple SclerosisLast Updated:May 19, 2008Completed
Condition(s):Obesity; HypertensionLast Updated:February 20, 2024Recruiting
Condition(s):Stress, JobLast Updated:February 1, 2024Not yet recruiting
Condition(s):Relapsing Remitting Multiple SclerosisLast Updated:October 16, 2015Completed
Condition(s):Glucose Test Site BleedingLast Updated:December 30, 2022Completed
Condition(s):Epidermylosis BullosaLast Updated:October 12, 2006Completed
Condition(s):GlaucomaLast Updated:October 12, 2023Recruiting
Condition(s):Kidney Transplantation for More Than One Year; Patients With a Kidney Transplantation on CyclosporineLast Updated:August 19, 2022Recruiting
Condition(s):SmokingLast Updated:May 3, 2023Completed
Condition(s):Healthy SubjectLast Updated:December 21, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.